Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Teleflex IncorporatedNYSE: TFX
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns positive
Q2 FY2026 accounts receivables was $1.37M, compared with -$36.57M a year earlier. Trailing-twelve-month accounts receivables was -$67.5M. Over 3 fiscal years it compounded at +30.5% a year.
Context
- Accounts receivables amounted to 4.3% of revenue in FY2025, up 3.4 pp from a year earlier.
- Accounts receivables grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near $1.37M or moves back toward the trailing-twelve-month quarterly average of -$16.87M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (85.53M) USD
- Year-over-year change
- -206.0%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (85.53M) | -206.0% |
| FY2024 | 2024-12-31 | (27.95M) | -77.3% |
| FY2023 | 2023-12-31 | (15.76M) | +59.0% |
| FY2022 | 2022-12-31 | (38.46M) | -6309.8% |
| FY2021 | 2021-12-31 | (600K) | — |
Accounts Receivables vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +15.6% is the 5th highest of 9, against a peer median of +19.2%.
- Accounts receivables amounts to 2.6% of revenue for TFX, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $151.44M USD | +1.2% | — | 16.9% | |
| LTM Jun 2026 | $89.24M USD | +37.3% | +15.9% | 1.7% | |
| LTM Jun 2026 | $67.5M USD | +15.6% | +30.5% | 2.6% | |
| LTM Sep 2026 | $59.21M USD | +1175.7% | +30.0% | 3.4% | |
| LTM Jun 2026 | €59.16M EUR | +4904.7% | — | 4.8% | |
| LTM Jun 2026 | $44.38M USD | -720.6% | -40.6% | 4.4% | |
| LTM Jun 2026 | $27.35M USD | +233.4% | — | 6.2% | |
| LTM Sep 2026 | $9.85M USD | -15.4% | -43.5% | 0.6% | |
| LTM Sep 2026 | $3.29M USD | -94.2% | — | 0.7% | |
| LTM Jun 2026 | $0 USD | — | — | — | |
| LTM Sep 2026 | $0 USD | — | +334.4% | 0.0% | |
| Peer median (excluding TFX) | — | +19.2% | +15.9% | 3.4% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | 58.53M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| Deferred Income Tax | (110.24M) | (13.01M) | (13.05M) | 0 | (100.97M) |
| Stock-Based Compensation | 22.94M | 27.22M | 31.47M | 31.35M | 0 |
| Change in Working Capital | 127.35M | (239.96M) | (111.77M) | (1.82M) | (81.09M) |
| Accounts Receivables | (600K) | (38.46M) | (15.76M) | (27.95M) | (85.53M) |
| Inventory | (11.14M) | (110.69M) | (41.07M) | 1.72M | 84.04M |
| Accounts Payables | 94.02M | (24.79M) | (31.26M) | 9.67M | (8.28M) |
| Other Working Capital | 45.06M | (66.03M) | (23.68M) | 14.74M | (71.31M) |
| Other Non-Cash Items | (111.36M) | (25.84M) | 5.55M | 261.94M | 286.46M |
| Operating Cash Flow | 651.42M | 342.14M | 510.64M | 635.74M | 340.68M |
| Capital Expenditures | (71.62M) | (79.19M) | (91.44M) | (126.43M) | (95.24M) |
| Acquisitions (Net) | 220.32M | (186M) | (588.92M) | (120K) | (825.15M) |
| Purchases of Investments | (18.42M) | (22.3M) | (11.3M) | (7.3M) | (5M) |
| Sales of Investments | 7.3M | 7.3M | 7.3M | 7.3M | 0 |
| Other Investing Activities | 19.15M | 22.24M | 63.13M | 27.2M | 76.19M |
| Investing Cash Flow | 156.74M | (257.94M) | (621.23M) | (99.36M) | (849.19M) |
| Debt Repayment | (634.5M) | (145.45M) | 101.25M | (161.5M) | 982.04M |
| Common Stock Issued | 11.1M | 4.31M | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (4.31M) | 0 | (200M) | (300M) |
| Dividends Paid | (63.65M) | (63.79M) | (63.9M) | (63.54M) | (60.27M) |
| Other Financing Activities | (28.77M) | (8.27M) | 1.19M | 3.12M | (10.23M) |
| Financing Cash Flow | (715.82M) | (217.51M) | 38.54M | (421.93M) | 611.54M |
| Effect of Forex Changes | (23.13M) | (19.74M) | 2.86M | (9.65M) | (29.35M) |
| Net Change in Cash | 69.2M | (153.05M) | (69.19M) | 104.8M | 73.68M |
| Free Cash Flow | 579.8M | 262.95M | 419.2M | 509.31M | 245.44M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.